CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
GC | Group-specific component (vitamin D binding protein) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CHST4 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 | Predicted secreted proteins
| | | | | Tissue enriched |
RALYL | RALY RNA binding protein-like | | | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NXF3 | Nuclear RNA export factor 3 | | | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MUC5B | Mucin 5B, oligomeric mucus/gel-forming | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN2 | Claudin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CPA3 | Carboxypeptidase A3 (mast cell) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTHRC1 | Collagen triple helix repeat containing 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FNDC1 | Fibronectin type III domain containing 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPBAR1 | G protein-coupled bile acid receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LGALS2 | Lectin, galactoside-binding, soluble, 2 | | | | | | Tissue enhanced |
LIF | Leukemia inhibitory factor | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LYPD6 | LY6/PLAUR domain containing 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
MFAP2 | Microfibrillar-associated protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
OLFML2B | Olfactomedin-like 2B | Predicted secreted proteins
| | | | | Tissue enhanced |
ONECUT2 | One cut homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
SERPINA4 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SNAI1 | Snail family zinc finger 1 | Transcription factors
| | | | | Tissue enhanced |
SYT13 | Synaptotagmin XIII | | | | | | Tissue enhanced |
TNFAIP6 | Tumor necrosis factor, alpha-induced protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TNFSF18 | Tumor necrosis factor (ligand) superfamily, member 18 | Predicted membrane proteins
| | | | | Tissue enhanced |